• Profile
Close

Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment

BMC Cardiovascular Disorders May 04, 2021

Zhang RF, Ma CM, Wang N, et al. - This investigation was carried out to define the apt initial dosage of heparin during radiofrequency catheter ablation (RFCA) among patients suffering from atrial fibrillation (AF) taking uninterrupted nonvitamin K antagonist oral anticoagulant (NOAC) treatment. This analysis involved 187 consecutive AF patients who had their first RFCA. An initial heparin dose of 100 U/kg was given in the warfarin group (control group: n = 38). Patients receiving NOACs were randomly split into 3 NOAC categories (NG: n = 149), NG110, NG120, and NG130, and were given initial heparin doses of 110 U/kg, 120 U/kg, and 130 U/kg, respectively. According to findings, an adequate intraprocedural anticoagulant effect can be offered by an initial heparin dosage of 120 U/kg or 130 U/kg for patients with AF on uninterrupted NOAC treatment who had RFCA, and dosage of 130 U/kg permitted activated clotting time to reach the target earlier.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay